Additionally, a previous study suggested the presence of the co-expression of ISL1 and KDM6B in NAFLD and that ISL1 could interact with KDM6B (Wang et al. 2016). The gene discussed is ISL1; the disease is metabolic dysfunction-associated steatotic liver disease.